Related Experiment Video
Updated: May 21, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Targeting processive transcription for Myc-driven circuitry in medulloblastoma.
Lays Martin Sobral1, Faye M Walker1, Krishna Madhavan1
1Morgan Adams Foundation Pediatric Brain Tumor Research Program, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Targeting CDK9, a dependency in Myc-amplified medulloblastoma (Myc-MB), shows promise. Inhibiting CDK9 and CDK7 disrupts tumor growth programs, offering a new therapeutic strategy for high-risk childhood brain tumors.
Area of Science:
- Pediatric oncology
- Molecular biology
- Cancer genetics
Background:
- Medulloblastoma is the most common malignant pediatric brain tumor.
- Myc-amplified medulloblastoma (Myc-MB) has poor outcomes despite treatment.
- Myc drives pro-survival pathways, but direct targeting is difficult.
Purpose of the Study:
- Identify therapeutic vulnerabilities in Myc-MB.
- Investigate CDK9 as a potential drug target.
- Evaluate CDK9/7 inhibitors for Myc-MB treatment.
Main Methods:
- CRISPR-Cas9 screens to find Myc-MB dependencies.
- Chromatin conformation capture (Hi-C) to map enhancer-promoter interactions.
- In vitro and xenograft models treated with CDK9/7 inhibitors.
Main Results:
- CDK9 identified as a conserved dependency in Myc-MB across multiple screens.
- CDK9 inhibition is effective and synergistic with CDK7 inhibition.
- Inhibiting CDK9/7 disrupts enhancer-promoter activity and downregulates Myc programs, reducing tumor growth.
Conclusions:
- CDK9 inhibition is a promising therapeutic strategy for Myc-MB.
- Targeting transcriptional CDKs offers an indirect approach to drugging Myc-driven circuitry.
- This study provides a rationale for clinical investigation of CDK9 inhibitors in Myc-MB.
More Related Videos
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Master Transcription Regulators
Somatic to iPS Cell Reprogramming
Abnormal Proliferation
Transcription Initiation
The promoters and enhancers and their accessory proteins allow tight regulation of...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...